Literature DB >> 30614256

Mesenchymal stem cells-microvesicle-miR-451a ameliorate early diabetic kidney injury by negative regulation of P15 and P19.

Ling Zhong1,2, Guangneng Liao1, Xiaojiao Wang1, Lan Li1, Jie Zhang1, Younan Chen1, Jingping Liu1, Shuyun Liu1, Lingling Wei3, Wengeng Zhang4, Yanrong Lu1.   

Abstract

Entities:  

Keywords:  Mesenchymal stem cells; cell cycle; epithelial mesenchymal transformation; miR-451a; microvesicles

Year:  2019        PMID： 30614256      PMCID： PMC6384448          DOI： 10.1177/1535370218819726

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  49 in total

1.  Kidney regeneration: any prospects?

Authors:  Paola Romagnani
Journal:  Contrib Nephrol       Date:  2011-06-09       Impact factor: 1.580

Review 2.  Role of oxidative stress in diabetic kidney disease.

Authors:  Fayaz A Hakim; Axel Pflueger
Journal:  Med Sci Monit       Date:  2010-02

3.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

4.  Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.

Authors:  Fernando Ezquer; Marcelo Ezquer; Valeska Simon; Fabian Pardo; Alejandro Yañez; Daniel Carpio; Paulette Conget
Journal:  Biol Blood Marrow Transplant       Date:  2009-11       Impact factor: 5.742

Review 5.  Role of microRNA 21 in diabetes and associated/related diseases.

Authors:  Durairaj Sekar; Basam Venugopal; Punitha Sekar; Krishnan Ramalingam
Journal:  Gene       Date:  2016-01-27       Impact factor: 3.688

6.  E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma.

Authors:  K Araki; T Shimura; H Suzuki; S Tsutsumi; W Wada; T Yajima; T Kobayahi; N Kubo; H Kuwano
Journal:  Br J Cancer       Date:  2011-11-08       Impact factor: 7.640

7.  Bi-directional exchange of membrane components occurs during co-culture of mesenchymal stem cells and nucleus pulposus cells.

Authors:  Sandra Strassburg; Nigel W Hodson; Patrick I Hill; Stephen M Richardson; Judith A Hoyland
Journal:  PLoS One       Date:  2012-03-15       Impact factor: 3.240

8.  Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury.

Authors:  Stefania Bruno; Cristina Grange; Federica Collino; Maria Chiara Deregibus; Vincenzo Cantaluppi; Luigi Biancone; Ciro Tetta; Giovanni Camussi
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

9.  Clustering and conservation patterns of human microRNAs.

Authors:  Yael Altuvia; Pablo Landgraf; Gila Lithwick; Naama Elefant; Sébastien Pfeffer; Alexei Aravin; Michael J Brownstein; Thomas Tuschl; Hanah Margalit
Journal:  Nucleic Acids Res       Date:  2005-05-12       Impact factor: 16.971

Review 10.  Mesenchymal stem cell-derived microparticles: a promising therapeutic strategy.

Authors:  Xi Tan; Yong-Zhen Gong; Ping Wu; Duan-Fang Liao; Xi-Long Zheng
Journal:  Int J Mol Sci       Date:  2014-08-18       Impact factor: 5.923
View more
  13 in total

1.  Mesenchymal stem cells alleviate hypoxia-induced oxidative stress and enhance the pro-survival pathways in porcine islets.

Authors:  Yixiong Tan; Wei Nie; Cheng Chen; Xuesong He; Yuzhi Xu; Xiaoqian Ma; Juan Zhang; Mengqun Tan; Pengfei Rong; Wei Wang
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-01

Review 2.  Stem cell-based treatment of kidney diseases.

Authors:  Binbin Pan; Guoping Fan
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-11

3.  miR-451 Loaded Exosomes Are Released by the Renal Cells in Response to Injury and Associated With Reduced Kidney Function in Human.

Authors:  Manju Kumari; Aradhana Mohan; Carolyn M Ecelbarger; Amit Gupta; Narayan Prasad; Swasti Tiwari
Journal:  Front Physiol       Date:  2020-04-08       Impact factor: 4.566

Review 4.  Mesenchymal stem cells and extracellular vesicles in therapy against kidney diseases.

Authors:  Yuling Huang; Lina Yang
Journal:  Stem Cell Res Ther       Date:  2021-03-31       Impact factor: 6.832

Review 5.  Potential Therapeutic Effect and Mechanisms of Mesenchymal Stem Cells-Extracellular Vesicles in Renal Fibrosis.

Authors:  Chunling Liao; Guangyong Chen; Qian Yang; Yiping Liu; Tianbiao Zhou
Journal:  Front Cell Dev Biol       Date:  2022-03-11

Review 6.  The Multi-Therapeutic Role of MSCs in Diabetic Nephropathy.

Authors:  Yi Wang; Su-Kang Shan; Bei Guo; Fuxingzi Li; Ming-Hui Zheng; Li-Min Lei; Qiu-Shuang Xu; Muhammad Hasnain Ehsan Ullah; Feng Xu; Xiao Lin; Ling-Qing Yuan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-07       Impact factor: 5.555

Review 7.  Mesenchymal stem cell-derived extracellular vesicles in therapy against fibrotic diseases.

Authors:  Yuling Huang; Lina Yang
Journal:  Stem Cell Res Ther       Date:  2021-08-04       Impact factor: 6.832

8.  Mesenchymal Stem Cells Attenuate Diabetic Lung Fibrosis via Adjusting Sirt3-Mediated Stress Responses in Rats.

Authors:  Yang Chen; Fuping Zhang; Di Wang; Lan Li; Haibo Si; Chengshi Wang; Jingping Liu; Younan Chen; Jingqiu Cheng; Yanrong Lu
Journal:  Oxid Med Cell Longev       Date:  2020-02-04       Impact factor: 6.543

Review 9.  A systematic review and meta-analysis of cell-based interventions in experimental diabetic kidney disease.

Authors:  LaTonya J Hickson; Tala Abedalqader; Gift Ben-Bernard; Jayla M Mondy; Xiaohui Bian; Sabena M Conley; Xiangyang Zhu; Sandra M Herrmann; Aleksandra Kukla; Elizabeth C Lorenz; Seo Rin Kim; Bjorg Thorsteinsdottir; Lilach O Lerman; M Hassan Murad
Journal:  Stem Cells Transl Med       Date:  2021-06-09       Impact factor: 6.940

Review 10.  The Nephroprotective Properties of Extracellular Vesicles in Experimental Models of Chronic Kidney Disease: a Systematic Review.

Authors:  Natalia Nowak; Masayuki Yamanouchi; Eiichiro Satake
Journal:  Stem Cell Rev Rep       Date:  2021-06-10       Impact factor: 5.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.